B cell dysregulation during acute COVID-19 is transient

Key Points

• B cell dysregulation occurs transiently during acute COVID-19, impacting overall immune health.
• Findings indicate significant changes in antibody production within the first four weeks of infection.
• Observational analysis reveals alterations in b cells amid cytokine storms during acute illness.
• These results underscore the importance of monitoring b cell activity for long-term COVID-19 implications.